Table 1

Clinical characteristics of patients with malignant melanoma (n=19)

Median age, years (range)63 (29–84)
Disease stage
Progress after blood withdrawal
pSTAT3 (in M-MDSC) classification
Stage distribution in ‘pSTAT3 high’ group
Stage distribution in ‘pSTAT3 low’ group
Progressive patients in pSTAT3 high group
 No progress4
Progressive patients in pSTAT3 low group
 No progress7
  • M-MDSC, monocytic myeloid-derived suppressor cell.